nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Amantadine: an old drug reborn
|
Pahwa, Rajesh |
|
|
20 |
12 |
p. 975-977 |
artikel |
2 |
Amantadine in the treatment of Parkinson's disease and other movement disorders
|
Rascol, Olivier |
|
|
20 |
12 |
p. 1048-1056 |
artikel |
3 |
Better buildings for elderly people to thrive
|
O'Connor, Aine |
|
|
20 |
12 |
p. 988-989 |
artikel |
4 |
Correction to Lancet Neurol 2018; 17: 1061–82
|
|
|
|
20 |
12 |
p. e7 |
artikel |
5 |
Correction to Lancet Neurol 2019; 18: 56–87
|
|
|
|
20 |
12 |
p. e7 |
artikel |
6 |
Correction to Lancet Neurol 2018; 17: 954–76
|
|
|
|
20 |
12 |
p. e7 |
artikel |
7 |
Correction to Lancet Neurol 2018; 17: 939–53
|
|
|
|
20 |
12 |
p. e7 |
artikel |
8 |
Correction to Lancet Neurol 2021; 20: 1038–47
|
|
|
|
20 |
12 |
p. e7 |
artikel |
9 |
Erythropoietin and optic neuritis in the TONE study
|
Costello, Fiona |
|
|
20 |
12 |
p. 970-971 |
artikel |
10 |
Gabriel Bsteh
|
|
|
|
20 |
12 |
p. 984 |
artikel |
11 |
Georgios Tsivgoulis: in top gear
|
Burton, Adrian |
|
|
20 |
12 |
p. 983 |
artikel |
12 |
Intracranial pressure monitoring and unfavourable outcomes
|
Welling, Leonardo C |
|
|
20 |
12 |
p. 978-979 |
artikel |
13 |
Intracranial pressure monitoring and unfavourable outcomes
|
Chesnut, Randall M |
|
|
20 |
12 |
p. 978 |
artikel |
14 |
Intracranial pressure monitoring and unfavourable outcomes – Authors' reply
|
Citerio, Giuseppe |
|
|
20 |
12 |
p. 979 |
artikel |
15 |
Lost in plain sight
|
Wijdicks, Eelco |
|
|
20 |
12 |
p. 987-988 |
artikel |
16 |
Neuromodulation in epilepsy: state-of-the-art approved therapies
|
Ryvlin, Philippe |
|
|
20 |
12 |
p. 1038-1047 |
artikel |
17 |
New therapies for Pompe disease: are we closer to a cure?
|
Puertollano, Rosa |
|
|
20 |
12 |
p. 973-975 |
artikel |
18 |
Overall fraction of disease attributable to multiple dependent risk factors: a new formula
|
Niedhammer, Isabelle |
|
|
20 |
12 |
p. 979-980 |
artikel |
19 |
Paediatric multiple sclerosis: a lesson from TERIKIDS
|
Sormani, Maria Pia |
|
|
20 |
12 |
p. 971-973 |
artikel |
20 |
Safe laboratory management of prions and proteopathic seeds
|
Mead, Simon |
|
|
20 |
12 |
p. 981 |
artikel |
21 |
Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial
|
Diaz-Manera, Jordi |
|
|
20 |
12 |
p. 1012-1026 |
artikel |
22 |
Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trial
|
Schoser, Benedikt |
|
|
20 |
12 |
p. 1027-1037 |
artikel |
23 |
Safety and efficacy of erythropoietin for the treatment of patients with optic neuritis (TONE): a randomised, double-blind, multicentre, placebo-controlled study
|
Lagrèze, Wolf A |
|
|
20 |
12 |
p. 991-1000 |
artikel |
24 |
Safety and efficacy of teriflunomide in paediatric multiple sclerosis (TERIKIDS): a multicentre, double-blind, phase 3, randomised, placebo-controlled trial
|
Chitnis, Tanuja |
|
|
20 |
12 |
p. 1001-1011 |
artikel |
25 |
Supernova: remembering me as I was
|
Morgan, Jules |
|
|
20 |
12 |
p. 990 |
artikel |
26 |
20th Anniversary photography competition: neurology for zoomers
|
Becker-Barroso, Elena |
|
|
20 |
12 |
p. 977 |
artikel |
27 |
The East Asian Parkinson Disease Genomics Consortium
|
Mok, Kin Y |
|
|
20 |
12 |
p. 982 |
artikel |
28 |
The International Brain Initiative: collaboration in progress
|
The Lancet Neurology, |
|
|
20 |
12 |
p. 969 |
artikel |
29 |
The International Brain Initiative: enabling collaborative science
|
Quaglio, Gianluca |
|
|
20 |
12 |
p. 985-986 |
artikel |
30 |
Trials for neurodegenerative diseases: time to innovate
|
Mehta, Arpan R |
|
|
20 |
12 |
p. 984 |
artikel |